A new drug developed by scientists at the Florey Institute of Neuroscience, and the School of Chemistry and Bio21 Institute at the University of Melbourne has dramatically improved clinical and cognitive symptoms of motor neurone disease, also called amyotrophic lateral sclerosis.
Motor neurone disease is a progressive, fatal neurodegenerative disease. Its key hallmark is the death of the brain cells that control muscle movements. This results in muscle weakness and eventually paralysis.
Patients usually die of respiratory failure within three years of diagnosis, and there are no treatments or disease-modifying therapies available.
In this dose-finding trial involving 32 patients, the group given the highest amount of the CuATSM compound showed improved lung function and cognitive ability, compared to the predicted declines observed in standard-of-care patients.
Further, treated patients showed a much slower overall disease progression as measured by a global disability score.
The clinical trial was led by Professor Dominic Rowe at Macquarie University, and Associate Professor Susan Mathers at Calvary Health Care Bethlehem, and sponsored by Collaborative Medicinal Development Pty Ltd with support from FightMND.
Professor Ashley Bush, Chief Scientific Officer of Collaborative Medicinal Development and director of the Melbourne Dementia Research Centre, said “This is the first human evidence for a disease-modifying drug for motor neurone disease. It is a huge breakthrough, and we look forward to confirming the positive results in a larger study soon.”
Associate Professor Kevin Barnham of the Florey, Associate Professor Anthony White at the Queensland Institute of Medical Research, and Professor Paul Donnelly and Associate Professor Peter Crouch from the University of Melbourne, developed and tested CuATSM over a 15-year period.
After showing its therapeutic potential for motor neurone disease in pre-clinical models, the researchers founded a company and licenced the compound to Collaborative Medicinal Development, to take the drug into human studies.
Professor Donnelly said, “It is gratifying to see such promising results made possible by collaborative fundamental research at the interface between chemistry and biology.”
The Latest on: Motor neurone disease
via Google News
The Latest on: Motor neurone disease
- Inspirational Whitley Bay footballer opens up about 10-year battle with motor neurone diseaseon January 22, 2020 at 9:44 am
A decade on from his devastating diagnosis former Whitley Bay footballer lifts the lid on how he has lives life with debilitating nerve condition ...
- Grandmother with Motor Neurone Disease urges sufferers to sign up to 'ground-breaking' new drug trialon January 22, 2020 at 7:55 am
A grandmother from Annan who is living with Motor Neurone Disease is urging other people with the condition to take part in a 'ground-breaking' new clinical trial. Anne Robertson was a self-confessed ...
- Ground breaking drugs trial brings fresh hope for those battling Motor Neurone Diseaseon January 22, 2020 at 6:00 am
Wishaw dad Ged Rooney has been living with the condition for a decade A Wishaw grandad who has battled Motor Neurone Disease for the last 10 years hopes a ground breaking drugs trial will be a crucial ...
- Leeds Rhinos legend Rob Burrow makes final cameo after being diagnosed with motor neurone diseaseon January 17, 2020 at 3:01 pm
Rob Burrow was last month diagnosed with motor neurone disease and on Sunday made his final appearance for Leeds Rhinos during Jamie Jones-Buchanan’s testimonial against Bradford Bulls. It was one of ...
- Motor neurone disease trial offered to hundreds of patientson January 15, 2020 at 5:27 pm
It’s been described as one of the few remaining illnesses that is still largely a mystery, and yet it claims hundreds of lives in the UK each year. But now the largest clinical trial in a generation, ...
- Doddie Weir backs clinical trial to help fight Motor Neurone Diseaseon January 15, 2020 at 11:06 am
The Scots rugby star was diagnosed with MND three years ago and began his charity My Name’5 (CORR) Doddie Foundation to help fight the disease and help other sufferers. A search is on for hundreds of ...
- Motor neurone disease: 'Hope is a real positive'on January 14, 2020 at 4:00 pm
Alan Gray can no longer walk after being diagnosed with motor neurone disease in 2017. There is no effective treatment or cure, and half of the 1,500 people who are diagnosed each year die within 24 ...
- Rugby League legend Rob Burrow speaks out about his motor neurone disease diagnosison January 12, 2020 at 4:59 pm
Rugby League great Rob Burrow says he "doesn't want people feeling sorry for me" after he was recently diagnosed with motor neurone disease (MND). Burrow, 37, played for Leeds Rhinos, England and ...
- Tearful Rob Burrow thanks packed stadium after motor neurone disease diagnosison January 12, 2020 at 12:39 pm
Leeds Rhinos great Rob Burrow thanked fans for their support at a sell-out benefit game following his diagnosis with motor neurone disease. The tearful 37-year-old carried his young son Jackson onto ...
- Rob Burrow holds back tears after Leeds Rhinos legend was diagnosed with motor neurone diseaseon January 12, 2020 at 8:02 am
Rob Burrow held back tears as he took to the field with his three children in tow for a fundraising match after the Leeds Rhinos legend was diagnosed with motor neurone disease. The 37-year-old has ...
via Bing News